Clinical Trial Update: Efficacy of Low-dose Dexmedetomidine to Prevent Delirium in Liver Transplant Patients [Phase 4]

View source ↗

Summary

Phase 4 trial assessing low-dose dexmedetomidine to prevent delirium after liver transplantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Drugs mentioned

• Dexmedetomidine (low-dose) (dexmedetomidine)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Liver Transplantation | Phase 4 | Status: COMPLETED